The ERCC6 Gene and Age-Related Macular Degeneration

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Baas, Dominique C ^a   Despriet, Dominiek D ^b   Gorgels, Theo G M F ^a   Bergeron Sawitzke, Julie ^c   Uitterlinden, André G ^b   Hofman, Albert ^b   van Duijn, Cornelia M ^b   Merriam, Joanna E ^d   Smith, R Theodore ^d   Barile, Gaetano R ^d   ten Brink, Jacoline B ^a   Vingerling, Johannes R ^b   Klaver, Caroline C W ^b   Allikmets, Rando ^d   Dean, Michael ^e   Bergen, Arthur A B ^a,f  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c SAIC FREDERICK INC   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ERCC6 PROTEIN, HUMAN; HELICASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; ERCC6 GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PIGMENT EPITHELIUM; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; RNA ANALYSIS; AGED; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; PATHOLOGY; PROMOTER REGION; RETINA MACULA DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DNA HELICASES; DNA REPAIR ENZYMES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MACULAR DEGENERATION; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78249244159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013786     Document Type: Article

References (50)

1. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122: 564-572.
2. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, et al. (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205-210.
3. Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, et al. (1998) Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116: 1646-1651.
4. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123: 321-327.
5. Edwards AO, Ritter R, III, Abel KJ, Manning A, Panhuysen C, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
6. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
7. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
8. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
9. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, et al. (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314: 989-992.
10. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, et al. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14: 3227-3236.
11. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with agerelated macular degeneration. Nat Genet 38: 458-462.
12. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, et al. (2007) Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 39: 1200-1201.
13. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
14. Baas DC, Ho L, Ennis S, Merriam JE, Tanck MW, et al. (2010) The complement component 5 gene and age-related macular degeneration. Ophthalmology 117: 500-511.
15. Wang G, Spencer KL, Scott WK, Whitehead P, Court BL, et al. (2010) Analysis of the indel at the ARMS2 39UTR in age-related macular degeneration. Hum Genet 127: 595-602.
16. Yang Z, Tong Z, Chen Y, Zeng J, Lu F, et al. (2010) Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration. PLoS Genet 6: e1000836.
17. Kanda A, Chen W, Othman M, Branham KE, Brooks M, et al. (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A 104: 16227-16232.
18. Booij JC, van Soest S, Swagemakers SM, Essing AH, Verkerk AJ, et al. (2009) Functional annotation of the human retinal pigment epithelium transcriptome. BMC Genomics 10: 164.
19. Tuo J, Ning B, Bojanowski CM, Lin ZN, Ross RJ, et al. (2006) Synergic effect of polymorphisms in ERCC6 59 flanking region and complement factor H on agerelated macular degeneration predisposition. Proc Natl Acad Sci U S A 103: 9256-9261.
20. Mallery DL, Tanganelli B, Colella S, Steingrimsdottir H, van Gool AJ, et al. (1998) Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome. Am J Hum Genet 62: 77-85.
21. Nance MA, Berry SA (1992) Cockayne syndrome: review of 140 cases. Am JMed Genet 42: 68-84.
22. Hanawalt PC (2002) Subpathways of nucleotide excision repair and their regulation. Oncogene 21: 8949-8956.
23. Venema J, Mullenders LH, Natarajan AT, van Zeeland AA, Mayne LV (1990) The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc Natl Acad Sci U S A 87: 4707-4711.
24. de Waard H, de Wit J, Gorgels TG, van den Aardweg G, Andressoo JO, et al. (2003) Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair (Amst) 2: 13-25.
25. Spivak G, Hanawalt PC (2006) Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UVsensitive syndrome fibroblasts. DNA Repair (Amst) 5: 13-22.
26. Tuo J, Jaruga P, Rodriguez H, Bohr VA, Dizdaroglu M (2003) Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8- hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEB J 17: 668-674.
27. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298-300.
28. van der Pluijm I, Garinis GA, Brandt RM, Gorgels TG, Wijnhoven SW, et al. (2007) Impaired genome maintenance suppresses the growth hormone-insulinlike growth factor 1 axis in mice with Cockayne syndrome. PLos Biol 5: e2.
29. Gorgels TG, van der Pluijm I, Brandt RM, Garinis GA, van Steeg H, et al. (2007) Retinal degeneration and ionizing radiation hypersensitivity in a mouse model for Cockayne syndrome. Mol Cell Biol 27: 1433-1441.
30. van der Horst GT, van Steeg H, Berg RJ, van Gool AJ, de Wit J, et al. (1997) Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 89: 425-435.
31. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
32. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, et al. (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107: 7401-7406.
33. Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134.
34. Shen JK, Dong A, Hackett SF, Bell WR, Green WR, et al. (2007) Oxidative damage in age-related macular degeneration. Histol Histopathol 22: 1301-1308.
35. Coleman HR, Chan CC, Ferris FL, III, Chew EY (2008) Age-related macular degeneration. Lancet 372: 1835-1845.
36. Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J (2003) Aging and genome maintenance: lessons from the mouse? Science 299: 1355-1359.
37. Wozniak K, Szaflik JP, Zaras M, Sklodowska A, Janik-Papis K, et al. (2009) DNA damage/repair and polymorphism of the hOGG1 gene in lymphocytes of AMD patients. J Biomed Biotechnol 2009 827562: 827562.
38. Dianov G, Bischoff C, Sunesen M, Bohr VA (1999) Repair of 8-oxoguanine in DNA is deficient in Cockayne syndrome group B cells. Nucleic Acids Res 27: 1365-1368.
39. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7: 403-422.
40. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, et al. (2007) The Rotterdam Study: objectives and design update. Eur J Epidemiol 22: 819-829.
41. (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119: 1439-1452.
42. Bergeron-Sawitzke J, Gold B, Olsh A, Schlotterbeck S, Lemon K, et al. (2009) Multilocus analysis of age-related macular degeneration. Eur J Hum Genet 17: 1190-1199.
43. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374.
44. (2001) The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age- Related Eye Disease Study Report Number 6. Am J Ophthalmol 132: 668-681.
45. Assink JJ, Tijmes NT, ten Brink JB, Oostra RJ, Riemslag FC, et al. (1997) A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. Am J Hum Genet 61: 934-939.
46. Hu X, Plomp A, Gorgels T, Brink JT, Loves W, et al. (2004) Efficient molecular diagnostic strategy for ABCC6 in pseudoxanthoma elasticum. Genet Test 8: 292-300.
47. van Soest SS, de Wit GM, Essing AH, ten Brink JB, Kamphuis W, et al. (2007) Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch's membrane. Mol Vis 13: 1608-1617.
48. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
49. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, et al. (2006) Complement factor H polymorphism, complement activators, and risk of agerelated macular degeneration. JAMA 296: 301-309.
50. Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3: 452-456.